Cambrex
CBM | US
Overview
Corporate Details
- ISIN(s):
- US1320111073
- LEI:
- 4Q9DLX2VIFGJMOYJ4Y35
- Country:
- United States of America
- Address:
- N/A
- Website:
- https://www.cambrex.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
Automate Your Workflow. Get a real-time feed of all Cambrex filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Cambrex
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cambrex via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops and commercializes nanoparticle vaccines for serious infectious diseases.
United States of America
NVAX
United States of America
NVAX
South Korea
229500
Develops medicines and devices for chronic diseases like diabetes, obesity, and rare disorders.
Denmark
NOVO
Denmark
NOVO
Develops novel oral drugs for CNS disorders, targeting suicidal depression and PTSD.
United States of America
NRXP
United States of America
NRXP
Develops safer anti-cancer medicines with ProTide technology to overcome cell resistance.
United States of America
NCNA
United States of America
NCNA
Develops & distributes health, cosmetic & pharma products from natural ingredients globally.
Hungary
NUTEX
Hungary
NUTEX
Develops abuse-deterrent transdermal patches to make potent drug delivery safer.
United States of America
NTRB
United States of America
NTRB
Designs targeted small molecule drugs for kinase-driven cancers to overcome treatment resistance.
United States of America
NUVL
United States of America
NUVL
A clinical-stage biopharma developing novel drugs for difficult-to-treat cancers.
United States of America
NUVB
United States of America
NUVB
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
United States of America
NVCT
United States of America
NVCT